Overview
Setting the standard for translational NAD⁺ research in regulated markets
CellVive NMN® (β-nicotinamide mononucleotide) is an Active Pharmaceutical Ingredient (API) exclusive to Longevity Life Science for supply in Australia and globally.
CellVive NMN® maintains energy levels by supporting NAD-dependent pathways.
Backed by multiple peer-reviewed human clinical trials, CellVive NMN® is produced using proprietary enzymatic synthesis to achieve >99% purity and manufactured to pharmaceutical standards.
NMN is now a permitted ingredient in listed medicines in Australia, after its addition to the Permitted Ingredients Determination.
CellVive NMN®
Australia’s only Permitted Nicotinamide Mononucleotide (NMN) for Use in Listed Medicines
Nicotinamide mononucleotide (NMN) is a molecule naturally found in the body and related to vitamin B3. CellVive NMN® plays a role in helping to maintain energy levels by supporting NAD-dependent pathways. NMN has become a focus of scientific research for its role in supporting such vital pathways.
15 +
human clinical trials
≥99 %
purity verified
Exclusive Supply
Longevity Life Sciences
SCIENTIFIC VALIDATION
Pharmaceutical-Standard Purity and Process
≥99%
CellVive NMN® delivers ≥99% purity through pharmaceutical-standard manufacturing, ensuring unmatched consistency, stability, and quality assurance.
15+ Clinical Trials
Backed by 15 clinical trials and Australian university partnerships.
Our Approach
Exclusive Supply
Available solely through Longevity Life Sciences, CellVive NMN® combines guaranteed supply assurance with collaborative scientific and regulatory support.
Evidence-based Active Pharmaceutical Ingredient
CellVive NMN® is produced to stringent pharmaceutical-standards, offering the scientific credibility and compliance to meet current market demand.
SyncoZymes
Our Dedicated Raw-Material Manufacturing Facility
SyncoZymes’ state-of-the-art green-manufacturing facility underpins our global leadership in NMN innovation. Based in Zhangjiang High-Tech Park, the GMP-certified site employs advanced biocatalysis and enzyme-technology platforms to deliver high-purity co-enzymes and health-industry intermediates. Committed to sustainability, SyncoZymes deploys green-chemical processes, low-impact waste management and energy-efficient production systems. As LLS’s exclusive manufacturing partner, this facility enables us to deliver world-class CellVive NMN® to Australia and global markets to pharmaceutical standards at scale.
Connect with us
Integrated Australian Business Bridging
Research
Innovation
Delivery
Redefining long-term health by translating research into health solutions
